Showing results (581-590 of 605) with videos related to

Sort By:
Pageof 61
Journal of Internal Medicine|December 20, 2020
Identification of IgG1 isotype phosphorylcholine antibodies for the treatment of inflammatory cardiovascular diseasesM R de Vries, M M Ewing, R C M de Jong, et al.
Genetic Epidemiology|November 30, 2007
Summary of contributions to GAW15 Group 13: candidate gene association studiesMariza de Andrade, Andrew S Allen, Dimitru Brinza, et al.
Plos One|April 18, 2015
Galectin-2 induces a proinflammatory, anti-arteriogenic phenotype in monocytes and macrophagesCansu Yıldırım, Daphne Y S Vogel, Maurits R Hollander, et al.
Science (New York, N.Y.)|March 30, 2019
Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infectionJohanna M Sweere, Jonas D Van Belleghem, Heather Ishak, et al.
BMC Geriatrics|August 23, 2011
[Cost] effectiveness of withdrawal of fall-risk increasing drugs versus conservative treatment in older fallers: design of a multicenter randomized controlled trial (IMPROveFALL-study)Klaas A Hartholt, Nicole D A Boyé, Nathalie Van der Velde, et al.
Molecular Nutrition & Food Research|August 8, 2019
Akkermansia muciniphila Exerts Lipid-Lowering and Immunomodulatory Effects without Affecting Neointima Formation in Hyperlipidemic APOE*3-Leiden.CETP MiceSaeed Katiraei, Margreet R de Vries, Alice H Costain, et al.
Nature Communications|March 31, 2021
Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trialPrasanna Jagannathan, Jason R Andrews, Hector Bonilla, et al.
Genes and Immunity|November 24, 2006
Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary interventionP S Monraats, F A S Kurreeman, D Pons, et al.
EMBO Molecular Medicine|July 21, 2011
The isoenzyme of glutaminyl cyclase is an important regulator of monocyte infiltration under inflammatory conditionsHolger Cynis, Torsten Hoffmann, Daniel Friedrich, et al.
Neuromuscular Disorders : NMD|July 2, 2013
Six minute walk test in type III spinal muscular atrophy: a 12month longitudinal studyE Mazzone, F Bianco, M Main, et al.
Pageof 61